American Express has experienced a notable surge in global coverage, with 11 mentions in recent monitoring reports, indicating increased international visibility.
Neuronata-R Retains Conditional Approval In South Korea
Neuronata-R retains its conditional approval in South Korea, allowing continued clinical use under specific conditions, with further evaluation pending.
Trump Media has reached settlements to resolve ongoing legal disputes, ending multiple lawsuits. Details of the agreements are not yet fully disclosed.
4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population
4DMT announces promising 2-year results from its PRISM Phase 2b clinical trial in wet AMD, indicating potential efficacy of its investigational therapy.